HAlejandroPretiMD

PubMed

• 1 citations
  Unconventional Path to Healing: Diagnostic Value of CMR in a Patient With Incessant VT
  Shaden Khalaf, Mohammad A. Hussain, Melina Awar, Hector Alejandro Preti, Mary R. Schwartz, Miguel Valderrábano, Faisal Nabi, Dipan J. Shah> ;JACC. Case Reports. 2019 Nov 20
• 5 citations
  Hypothalamic relapse of a cardiac large B-cell lymphoma presenting with memory loss, confabulation, alexia–agraphia, apathy, hypersomnia, appetite disturbances and dia...
  Natalia Ospina-García, Gustavo C. Román, Belen Pascual, Mary R. Schwartz, Hector Alejandro Preti> ;BMJ Case Reports. 2018 Aug 27
• Complement activation: an atypical presentation of an atypical syndrome
  Alfredo Iardino, Viviane M. Bunin, Luan D. Truong, Hector Alejandro Preti> ;BMJ Case Reports. 2017 Oct 30
• 1 citations
  Points to Remember: Practical Pearls in Onco-Cardiology.
  H. Alejandro Preti> ;Methodist Debakey Cardiovascular Journal. 2015 Oct 1
• 40 citations
  Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition.
  Jianguo Wen, Yongdong Feng, Wan Ting Huang, Haiyun Chen, Bing Liao, Lawrence Rice, Hector Alejandro Preti, Rammurti T. Kamble, Youli Zu, Douglas Ballon, Chung Che Chang> ;Leukemia Research. 2010 Jan 1
• 21 citations
  Prognostic impact of C-REL expression in diffuse large B-cell lymphoma
  Choladda V. Curry, April A. Ewton, Randall J. Olsen, Brent R. Logan, Hector Alejandro Preti, Yao Chang Liu, Sherrie L. Perkins, Chung Che Chang> ;Journal of Hematopathology. 2009 Feb 13
• 32 citations
  Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease.
  Francisco Vega, Chung Che Chang, Mary R. Schwartz, Hector Alejandro Preti, Mamoun Younes, April A. Ewton, Ray Verm, Elaine S. Jaffe> ;The American Journal of Surgical Pathology. 2006 Apr 1
• 72 citations
  Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon...
  Peter McLaughlin, Elihu H. Estey, Armand B. Glassman, Jorge E. Romaguera, Felipe Samaniego, Ana Ayala, Kimberly Hayes, Anne Marie Maddox, H. Alejandro Preti, Fredrick ...> ;Blood. 2004 Nov 16
• 16 citations
  Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemothe...
  Bouthaina S. Dabaja, Peter McLaughlin, Chul S. Ha, Barbara Pro, Christina A. Meyers, Lee F. Seabrooke, Richard B. Wilder, Athanassios P. Kyritsis, H. Alejandro Preti, ...> ;Cancer. 2003 Sep 1
• 25 citations
  Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
  Ahmed I. Younes, Hector Alejandro Preti, Fredrick B. Hagemeister, Patricia J. McLaughlin, J. E. Romaguera, Maria A Rodriguez, Barry I. Samuels, J. L. Palmer, Fernando ...> ;Annals of Oncology. 2001 Jul 1
• 50 citations
  Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: Update of the MDACC series
  Armando López-Guillermo, Fernando Cabanillas, Patricia J. McLaughlin, Terry K. Smith, Fredrick B. Hagemeister, Maria A Rodriguez, Jorge E. Romaguera, Ahmed I. Younes, ...> ;Annals of Oncology. 2000 Jan 1
• 114 citations
  Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
  Armando López-Guillermo, Fernando Cabanillas, Timothy I. McDonnell, Peter McLaughlin, Terry K. Smith, William C. Pugh, Fredrick B. Hagemeister, M. Alma Rodriguez, Jorg...> ;Blood. 1999 May 1
• 3 citations
  Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma.
  Jorge E. Romaguera, Fredrick B. Hagemeister, Patricia J. McLaughlin, Maria A Rodriguez, Carlos Bachier, Hector Alejandro Preti, Andreas H. Sarris, Donna M. Weber, Ahme...> ;Leukemia & Lymphoma. 1998 Jan 1
• 8 citations
  Paclitaxel plus high‐dose cyclosphosphamide with G‐CSF support in patients with relapsed and refractory aggressive non‐Hodgkin's lymphoma
  Anas Younes, Jorge E. Romaguera, O. Mesina, Frederick B. Hagemeister, Andreas H. Sarris, Maria A Rodriguez, Peter McLaughlin, Hector Alejandro Preti, Carlos Bachier, F...> ;British Journal of Haematology. 1998 Dec 1
• 128 citations
  The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas
  Armando López-Guillermo, Fernando Cabanillas, Peter McLaughlin, Terry K. Smith, Fredrick B. Hagemeister, Maria Alma Rodriguez, Jorge E. Romaguera, Anas Younes, Andreas...> ;Blood. 1998 Apr 15
• 98 citations
  Prognostic Value of Serum Interleukin-6 in Diffuse Large-cell Lymphoma
  H. Alejandro Preti, Fernando Cabanillas, Moshe Talpaz, Susan L. Tucker, John F. Seymour, Razelle Kurzrock> ;Annals of Internal Medicine. 1997 Aug 1
• 37 citations
  Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis
  Hector Alejandro Preti, Yang O. Huh, Susan O'Brien, Michael Andreeff, Sherry T. Pierce, Michael J. Keating, Hagop M. Kantarjian> ;Cancer. 1995 Nov 1
• 91 citations
  Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients.
  H. Alejandro Preti, Susan O'Brien, Sergio Giralt, Miloslav Beran, Sherry Pierce, Hagop M. Kantarjian> ;The American Journal of Medicine. 1994 Jul 1
• 1 citations
  Acute lymphocytic leukemia in adults: an update.
  Hector Alejandro Preti, Hagop M. Kantarjian> ;Texas Medicine. 1994 Jan 1
• Join now to see all

Journal Articles

• Prognostic impact of C-REL expression in diffuse large B-cell lymphoma  
  Curry CV, Ewton A, Olsen RJ, Logan B, Liu YC, Perkins SL and Chang CC, J Hematopathol, 1/1/2009
• Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition  
  Jianguo Wen, Yongdong Feng, Wanting Huang, Haiyun Chen,Bing Liao, Lawrence Rice, Rammurti T Kamble,Youli Zu, Douglas J Ballon, Chung-Che Chang, Leukemia research, 1/1/2009
• Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma  
  Tsimberidou AM, McLaughlin P, Younes A, Rodriguez MA, Hagemeister FB, Sarris A, Romaguera J, Hess M, Smith TL, Yang Y, Ayala A, Lee MS, Cabanillas F, Blood, 1/15/2002
• A phase II study of paclitaxel/topotecan in patients with refractory and relapsing aggressive non-Hodgkin’s lymphoma  
  Younes A, et al., Ann Oncol, 1/1/2001
• Safety of Fludarabine, Mitoxantrone, Dexamethasone combined with Rituximab in the treatment of stage IV indolent lymphoma  
  McLaughlin P, Hagemeister FB, Rodriguez MA, Sarris AH, Pate O, Younes A, Lee MS, Dang NH, Romaguerra JE, McAda N, Cabanillas F, Semin Oncol, 1/1/2000
• Interleukin-10 levels are often elevated in serum of adults with Hodgkin’s disease and are associated with inferior failure-free survival  
  Sarris AH, Klich KO, Pethambaram P, Tucker S, Jackow C, Messina O, Pugh W, Hagemeister FB, McLaughlin P, Rodriguez MA, Romaguera J, Fritsche H, Witzig T, Duvic M, Andr..., Ann Oncol, 1/1/1999
• Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin’s lymphoma after failure to cyt...  
  Romaguera JE, Rodriguez MA, Hagemeister FB, McLaughlin P, Rodriguez J, Younes A, Sarris AH, Cabanillas F, Invest New Drugs, 1/1/1999
• High dose chemotherapy for relapsed and refractory primary mediastinal lymphoma  
  Popat U, van Besien K, Przepiorka D, Pugh W, Amin K, Giralt S, Romaguera, Rodriguez A, Andersson B, Mehra R, Khouri I, de Lima M, Gajewski J, Cabanillas F, and Champlin R, J Clin Oncol, 1/1/1998
• Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin’s lymphoma  
  Younes A, Romaguera J, Mesina O, Hagemiester F, Sarris AH, Rodriguez MA, McLaughlin P, Bachier C, Cabanillas F, Br J Haematol, 1/1/1998
• Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin’s lymphoma  
  Romaguera JE, Hagemiester FB, McLaughlin P, Rodriguez MA, Bachier C, Sarris AH, Weber D, Younes A, Cabanillas F, Leuk Lymphoma, 1/1/1998
• Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously unt...  
  Romaguera JE, Rodriguez Diaz-Pavon J, Carias L, Hagemeister FB, McLaughlin P, Rodriguez MA, Sarris AH, Younes A, Bachier C, Llerena E, Cabanillas F, Leuk Lymphoma, 1/1/1998
• Prognostic value of Interleukin-6 in Diffuse Large cell Lymphoma  
  Cabanillas F, Talpaz M, Seymour J, Tucker S, Kurzrock R, Ann Int Med, 1/1/1997
• Use of the international prognostic index and the tumor score to detect poor risk patients with primary mediastinal large B-cell lymphoma: A study with 37 previously ...  
  Romaguera JE, Rodriguez J, Carías L, Bachier C, Hagemeister FB, McLaughlin P, Rodriguez MA, Sarris AH, Younes A, and Cabanillas F, J Clin Oncol, 1/1/1997
• Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin’s lymphoma  
  Younes A, Rodriguez A, McLaughlin P, North L, Sarris, A, Pate O, Hagemeister F, Romaguera J, Preti A, Bachier C, and Cabanillas F, Leuk Lymphoma, 1/1/1997
• Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial  
  Younes A, Ayoub JP, Sarris A, Hagemiester F, North L, Pate O, McLaughlin P, Rodriguez MA, Romaguera J, Kurzrock R, Bachier C, Smith T, Cabanillas F, Br J Haematol, 1/1/1997
• Incidence of Cytomegalovirus pneumonia in adult non-transplant cancer patients: Review of 9029 autopsies from 1964-1990  
  Mera JR, Whimbey E, Elting L, Luna M, Bruner JM, Williams TW, Bodey G, Goodrich JM, Journal of Infectious Disease, 1/1/1996
• Prognostic significance of positive myeloid markers in adult acute lymphocytic leukemia  
  Kantarjian HM, O'Brien S, Robertson L, Estey E, Beran M, Pierce S, Huh Y, Cancer, 1/1/1995
• Management of acute lymphocytic leukemia in adults  
  with Kantarjian HM, J Clin Oncol, 1/1/1994
• Characteristics and outcome of patients with acute lymphocytic leukemia and myeloperoxidase positive blasts by electron microscopy  
  Kantarjian HM, Estey E, Keating M, Huh Y, Andreeff M, Pierce S, Hirsch-Ginsberg C, Yee G, Sanford Stass, Hematologic Pathology, 1/1/1994
• Philadelphia chromosome positive adult acute lymphocytic leukemia - Characteristics, treatment results and prognosis  
  O'Brien S, Giralt S, Robertson L, Beran M, Koller C, Kantarjian H, Am J Med, 1/1/1994
• Hodgkin's disease with a mediastinal mass greater than 10 cm: Results of four different treatment approaches  
  Hagemeister FB, McLaughlin P, Swan F, Rodriguez A, Besa P, Cox JD, Allen PK, Cabanillas F, Annals of Oncology, 1/1/1994
• Acute lymphocytic leukemia (ALL) in the elderly: Characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen  
  Kantarjian HM, O'Brien S, Robertson L, Smith T, Estey E, Beran M, Pierce S, Keating M, Kantarjian H, British Journal of Hematology, 1/1/1994
• Join now to see all

Books/Book Chapters

• Primary Care Oncology 
  Chapter: Hodgkin’s Disease 
  with Seigler DW. B. Saunders1996
• Primary Care Oncology 
  Chapter: Non-Hodgkin’s Lymphoma 
  with Ritty AW. B. Saunders1996
• Cancer Bull 
  Chapter: Lymphoma in the elderly 
  Page 192 - 196with Cabanillas FC1995
• Medico Interamericano 
  Chapter: Linfoma en Pacientes de Edad Avanzada 
  Page 281 - 285Preti, A1995
• Texas Medicine 
  Chapter: Acute lymphocytic leukemia in adults: an update 
  Page 52 - 59with Kantarjian HM1994
• Medical Oncology a Comprehensive Review 
  Chapter: Testicular cancer 
  Page 295 - 311with Logothetis CJPRR, Huntington, New York1993
• The Non-Hodgkin's Lymphomas 
  Chapter: Cabanillas F 
  with Cabanillas FEditors: Ian T. Magrath.ArnoldEdition 2nd,1993
• Join now to see all

Abstracts/Posters

• Assessment of safety with abbreviated, weight-based bevacizumab infusions
  Hart J, Oholendt M, American Society of Clinical Pharmacology Annual Meeting, 1/1/2007
• Hypercalcemia caused by parathyroid hormone-related protein and ectopic production of intact parathyroid hormone in a patient with multiple malignancies
  Eid W, Wheeler TM, Sharma MD, Endo 2000 The Endocrine Society 82nd Annual Meeting, 1/1/2000
• Prognostic models for adults with Hodgkin’s disease (HD) treated with chemotherapy at M. D. Anderson
  Sarris AH, Messina O, Santiago M, Smith T, Hagemeister F, McLaughlin P, Rodriguez MA, Romaguera J, Ha C, Cox J, Pugh W, Cabanillas F, Proceeding of the American Society of Hematology, San Diego, 1/1/1997
• Hodgkin’s disease: Prognostic factors, including IL-10: A model for pathogenesis and a guide to therapy
  Sarris AH, Kliche KO, Smith T, Mesina O, Hagemeister F, McLaughlin P, Romaguera J, Rodriguez MA, Pugh W, Fuller L, Ha C, Cox J, Andreff M, Cabanillas F, International J of Oncology, 1/1/1997
• Phase II trial of infusional taxol and high dose cytoxan with granulocyte colony stimulatin factor (Filgrastim) for the treatment of relapsed/refractory intermediate g...
  Younes A, Romaguera J, Sarris A, North L, Hagemeister F, McLaughlin P, Rodriguez MA, Cabanillas F, Proceedings of the American Society of Clinical Oncology, 1/1/1996
• Paclitaxel (Taxol): An active new drug for the treatment of Non-Hodgkin’s Lymphoma (NHL)
  Younes A, Ayoub JP, Sarris AH, Hagemeister F, McLaughlin P, Rodriguez MA, Romaguera J, Bachier C, Cabanillas F, Proceeding of the Sixth International Conference on Malignant Lymphona, Lugano, Switzerland, 1/1/1996
• Stage IV low grade lymphoma (LGL): Randomized trial of two innovative regimens, with monitoring of bcl-2 by PCR
  McLaughlin P, Cabanillas, Younes A, Lee MS, Rodriguez MA, Hagemeister F, Sarris AH, Proceeding of the Sixth International Conference on Malignant Lymphoma, Lugano, Switzerland, 1/1/1996
• Interleukin-6 as a prognostic factor in diffuse large-cell lymphoma: A multivariate analysis
  Talpaz M, Cabanillas F, Seymour J, Tucker S, Kurzrock R, Blood, 1/1/1995
• Preliminary results of a Phase II trial of topotecan in patients with relapsing lymphoma
  Plunkett W, Sarris AH, Younes A, Hagemeister F, Rodriguez MA, Romaguera J, Mc Laughlin P, Bachier C, Cabanillas F, Blood, 1/1/1995
• The pretreatment serum beta-2 microglobulin is the most important feature predicting freedom from progression in clinically staged I-II Hodgkin’s disease treated wtih...
  Hagemeister FB, Mc Laughlin P, Rodriguez MA, Cox JD, Ha CS, Romaguera JE, Sarris AH, Younes A, Bachier C, Cabanillas F, Blood, 1/1/1995
• Serum b2-Microglobulin: An Important Prognostic Factor for Patients (PT) with Clinical-Staged (CS) I-II Hodgkin’s Disease (HD) Treated with NOVP and Radiotherapy (XT)
  Hagemeister F, Cox J, McLaughlin P, Rodriguez MA, Romaguera J, Younes A, Sarris A, Bachier C, Cabanillas F, Third International Symposium on Hodgkin’s Lymphoma, 1/1/1995
• Hodgkin's disease with a mediastinal mass greater than 10 cm: Results of four different treatment approaches
  Hagemeister FB, McLaughlin P, Swan F, Rodriguez A, Besa P, Cox JD, Allen PK, Cabanillas F, Fifth International Conference on Malignant Lymphona, Lugano, Switzerland, 1/1/1993
• New approaches in the treatment of Hodgkin's disease
  with Hagemeister FB, XVth Argentine Society of Hematology Meeting, 1/1/1993
• Acute ,lymphocytic leukemia (ALL) in the elderly: Characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen
  O'Brien S, Robertson L, Smith T, Estey E, Beran M, Pierce S, Keating M, Kantarjian H, Blood, 1/1/1993
• Prognostic significance of positive myeloid markers in adult acute lymphocytic leukemia
  Huh Y, O'Brien S, Robertson L, Estey E, Beran M, Pierce S, Keating M, Kantarjian H, Blood, 1/1/1993
• Characteristics and outcome of patients with acute lymphocytic leukemia (ALL) and myeloperoxidase positive blasts by electon microscopy (EM-MPO-positive)
  O'Brien S, Robertson L, Beran M, Huh Y, Koller C, Hirsch-Ginsberg C, Andreeff M, Stass S, Kantarjian H, Blood, 1/1/1993
• B2-microglobulin is capable of improving the prognostic discrimination of international index
  Swan F, Hagemeister F, McLaughlin P, Rodriguez M, Cabanillas F, Blood, 1/1/1993
• Philadelphia chromosome-positive adult acute lymphocytic leukemia - characteristics, treatment results, and prognosis
  O'Brien S, Giralt S, Robertson L, Beran M, Koller C, Kantarjian H, Blood, 1/1/1993
• Use of the International Prognostic Index (IPI) and the Tumor Score (TS) to detect poor-risk patients with primary mediastinal large B-cell lymphoma (PMLCL): A study w...
  Romaguera J, Rodriguez Diaz-Pavon J, Carias L, Hagemeister FB, McLaughlin P, Rodriguez MA, Sarris AH, Younes A, Llerena E, Cabanillas F, Proceedings of the Sixth International Conference on Malignant Lymphona, Lugano, Switzerland, 1/1/1993
• Incidence of Cytomegalovirus pneumonia in adult non-transplant cancer patients: Review of 9549 autopsies from 1964-1990
  Mera JR, Whimbey E, Luna M, Elting L, Vartivarian S, Williams TW, Bodey G, ICAC Meeting, Annaheim, 1/1/1992
• Activity of Taxol and high-dose Cytoxan with granulocyte colony stimulating factor (G-CSF) in 54 patients with relapsed/refractory intermediate grade non-hodgkin;s lym...
  Younes A, Romaguera J, North L, Messina O, Hagemeister F, Sarris A, McLaughlin P, Rodriguez MA, Cabanillas F, Proceeding of the American Society of Clinical Oncology
• Intensive reinduction with high-dose ifosfamide/VP16 and ifosfamide/novantrone followed by BEAM and stem cell transplant for recurrent lymphoma (NHL)
  van Besien K, Rodriguez MA, Amin K, Mehra R, Romaguera J, Giralt S, McLaughlin P, Andersson B, Hagemeister F, Gajewski J, Sarris A, Przepiorka D, Mirza N, Younes A, Ba..., Proceeding of the American Society of Clinical Oncology
• Join now to see all